Investigating the neuroprotective potential of repaglinide and development of novel pegylated nanocarriers for the management of metabolic disorder linked Alzheimer’s disease
| dc.contributor.author | Geetika | |
| dc.date.accessioned | 2024-05-11T05:51:45Z | |
| dc.date.available | 2024-05-11T05:51:45Z | |
| dc.date.issued | 2023 | |
| dc.description | Under the Supervision of Prof. Rajeev Taliyan | en_US |
| dc.identifier.uri | http://hdl.handle.net/10603/506014 | |
| dc.language.iso | en | en_US |
| dc.publisher | BITS PILANI, Pilani campus | en_US |
| dc.subject | Pharmacy | en_US |
| dc.subject | Neuroprotective potential | en_US |
| dc.subject | Metabolic disorder | en_US |
| dc.subject | Alzheimer’s disease | en_US |
| dc.title | Investigating the neuroprotective potential of repaglinide and development of novel pegylated nanocarriers for the management of metabolic disorder linked Alzheimer’s disease | en_US |
| dc.type | Thesis | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: